SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,496.26 -414.75
( -0.51%)

Global Indices

Nasdaq

52,431.30 -76.19
(-0.15%)

Dow Jones

7,621.14 -19.24
(-0.25%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,863.06 27.59
(0.25%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Brooks Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533543

INE650L01011

65.2643614

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BROOKS

67.34

194.39

EPS(TTM)

Face Value()

Div & Yield %

0.98

Back

GMM Pfaudler consolidated net profit declines 16.42% in the September 2026 quarter

Nov 05,2026

Net profit of GMM Pfaudler declined 16.42% to Rs 33.30 crore in the quarter ended September 2026 as against Rs 39.84 crore during the previous quarter ended September 2025. Sales rose 17.98% to Rs 1064.62 crore in the quarter ended September 2026 as against Rs 902.34 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1064.62	902.34	18
OPM %	10.35	13.47	-
PBDT	93.78	100.66	-7
PBT	50.28	61.69	-18
NP	33.30	39.84	-16

81,496.26 -414.75 ( -0.51%)

52,431.30 -76.19 (-0.15%)

7,621.14 -19.24 (-0.25%)

61,109.24 289.88 (0.48%)

10,863.06 27.59 (0.25%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)